Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000557955 | SCV000627256 | likely benign | Osteogenesis imperfecta type I | 2023-12-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001568011 | SCV001791800 | likely benign | not provided | 2020-01-21 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279335 | SCV002565528 | likely benign | Ehlers-Danlos syndrome | 2022-03-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002358440 | SCV002621100 | benign | Cardiovascular phenotype | 2022-05-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001568011 | SCV004564175 | likely benign | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing |